Author details

Full Name

Nir Hacohen

Affiliation

Broad Institute of MIT and Harvard

ORCID

Career Start Year

1989

Papers

228

H Index

Expertise

CM4AI Collaborator

Emma Lundberg (CM4AI)

PMID	Paper Title	Journal Title	Published Year
36972796	Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis.	J Hepatol	2024
38057668	Dictionary of immune responses to cytokines at single-cell resolution.	Nature	2024
36972796	Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis.	J Hepatol	2024
37291427	High-throughput RNA isoform sequencing using programmed cDNA concatenation.	Nat Biotechnol	2024
38057668	Dictionary of immune responses to cytokines at single-cell resolution.	Nature	2024
37291427	High-throughput RNA isoform sequencing using programmed cDNA concatenation.	Nat Biotechnol	2024
36701450	Low protease activity in B cell follicles promotes retention of intact antigens after immunization.	Science	2023
37653227	Author Correction: Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling.	Nat Biotechnol	2023
37906619	Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium.	Cancer Immunol Res	2023
37158243	Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients.	Hepatology	2023
37024582	Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer.	Nat Genet	2023
36827376	Microscale combinatorial stimulation of human myeloid cells reveals inflammatory priming by viral ligands.	Sci Adv	2023
37398281	The HLA-II immunopeptidome of SARS-CoV-2.	bioRxiv	2023
36702949	Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trial.	Nat Med	2023
36701450	Low protease activity in B cell follicles promotes retention of intact antigens after immunization.	Science	2023
36634707	Targeting TBK1 to overcome resistance to cancer immunotherapy.	Nature	2023
37066412	Spatial analysis of human lung cancer reveals organized immune hubs enriched for stem-like CD8 T cells and associated with immunotherapy response.	bioRxiv	2023
37001502	Cytotoxic CD4<sup>+</sup> TÂ cells eliminate senescent cells by targeting cytomegalovirus antigen.	Cell	2023
36747789	Systematically characterizing the roles of E3-ligase family members in inflammatory responses with massively parallel Perturb-seq.	bioRxiv	2023
36864091	Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade.	NPJ Precis Oncol	2023
36739287	ESCRT-dependent STING degradation inhibits steady-state and cGAMP-induced signalling.	Nat Commun	2023
37043539	A genome-wide optical pooled screen reveals regulators of cellular antiviral responses.	Proc Natl Acad Sci U S A	2023
36853705	Protocol for bulk RNA sequencing of enriched human neutrophils from whole blood and estimation of sample purity.	STAR Protoc	2023
37535729	<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancers.	Science	2023
37535724	Human STING is a proton channel.	Science	2023
37500887	Exposure of iPSC-derived human microglia to brain substrates enables the generation and manipulation of diverse transcriptional states in vitro.	Nat Immunol	2023
37906619	Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium.	Cancer Immunol Res	2023
37653227	Author Correction: Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling.	Nat Biotechnol	2023
37500887	Exposure of iPSC-derived human microglia to brain substrates enables the generation and manipulation of diverse transcriptional states in vitro.	Nat Immunol	2023
37535729	<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancers.	Science	2023
37535724	Human STING is a proton channel.	Science	2023
37024582	Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer.	Nat Genet	2023
37158243	Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients.	Hepatology	2023
37043539	A genome-wide optical pooled screen reveals regulators of cellular antiviral responses.	Proc Natl Acad Sci U S A	2023
37001502	Cytotoxic CD4<sup>+</sup> TÂ cells eliminate senescent cells by targeting cytomegalovirus antigen.	Cell	2023
37398281	The HLA-II immunopeptidome of SARS-CoV-2.	bioRxiv	2023
37066412	Spatial analysis of human lung cancer reveals organized immune hubs enriched for stem-like CD8 T cells and associated with immunotherapy response.	bioRxiv	2023
36853705	Protocol for bulk RNA sequencing of enriched human neutrophils from whole blood and estimation of sample purity.	STAR Protoc	2023
36747789	Systematically characterizing the roles of E3-ligase family members in inflammatory responses with massively parallel Perturb-seq.	bioRxiv	2023
36739287	ESCRT-dependent STING degradation inhibits steady-state and cGAMP-induced signalling.	Nat Commun	2023
36827376	Microscale combinatorial stimulation of human myeloid cells reveals inflammatory priming by viral ligands.	Sci Adv	2023
36634707	Targeting TBK1 to overcome resistance to cancer immunotherapy.	Nature	2023
36702949	Combined PD-1, BRAF and MEK inhibition in BRAF<sup>V600E</sup> colorectal cancer: a phase 2 trial.	Nat Med	2023
36864091	Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade.	NPJ Precis Oncol	2023
34826345	IRF3 inhibits IFN-Î³-mediated restriction of intracellular pathogens in macrophages independently of IFNAR.	J Leukoc Biol	2022
35513721	Prioritization of autoimmune disease-associated genetic variants that perturb regulatory element activity in T cells.	Nat Genet	2022
35762593	The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia.	mBio	2022
35508657	Landscape of helper and regulatory antitumour CD4<sup>+</sup> T cells in melanoma.	Nature	2022
36151395	In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer.	Nat Immunol	2022
36208629	Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients.	Cell Rep Med	2022

1 - 50 of 456

Tiago da Silva Medina

International Research Center, A.C.Camargo Cancer Center

Career Start Year 2016

Number of shared co-authors 0

Tao Wang

University of Texas Southwestern Medical Center

Career Start Year 2014

Number of shared co-authors 7

Bryan D Bryson

Massachusetts Institute of Technology, USA The Ragon Institute of MGH

Career Start Year 2012

Number of shared co-authors 9

Jinguo Chen

Center for Human Immunology

Career Start Year 2011

Number of shared co-authors 0

Alexander F Rosenberg

University of Alabama at Birmingham Birmingham

Career Start Year 2011

Number of shared co-authors 0

Nicolas Tchitchek

Sorbonne University INSERM

Career Start Year 2010

Number of shared co-authors 0

Joseph B Hiatt

Fred Hutchinson Cancer Center

Career Start Year 2009

Number of shared co-authors 18

David Langlais

McGill University

Career Start Year 2008

Number of shared co-authors 8

Wei Zhu

Georgia Cancer Center, Medical College of Georgia

Career Start Year 2008

Number of shared co-authors 0

Santiago J Carmona

AGORA Cancer Research Center

Career Start Year 2008

Number of shared co-authors 3

Deborah R Winter

Northwestern University Feinberg School of Medicine

Career Start Year 2007

Number of shared co-authors 5

Matthias Farlik

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences

Career Start Year 2007

Number of shared co-authors 2

Riyue Bao

UPMC Hillman Cancer Center

Career Start Year 2007

Number of shared co-authors 2

Brandon W Higgs

Translational and Clinical Data Sciences

Career Start Year 2006

Number of shared co-authors 0

Maggie Cam

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 2005

Number of shared co-authors 2

Ansuman T Satpathy

Stanford University

Career Start Year 2005

Number of shared co-authors 18

Kun Qu

University of Science and Technology of China

Career Start Year 2005

Number of shared co-authors 10

Amiran Dzutsev

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 2003

Number of shared co-authors 0

Andrew V Kossenkov

The Wistar Institute

Career Start Year 2003

Number of shared co-authors 1

Olivier Elemento

Meyer Cancer Center

Career Start Year 2002

Number of shared co-authors 25

David J Lynn

South Australian Health and Medical Research Institute

Career Start Year 2002

Number of shared co-authors 2

Ludmila Danilova

Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine

Career Start Year 2001

Number of shared co-authors 12

Sophia Derdak

Medical University of Vienna

Career Start Year 2001

Number of shared co-authors 2

David K Crossman

University of Alabama at Birmingham

Career Start Year 2000

Number of shared co-authors 0

Ning Jiang

The University of Texas at Austin

Career Start Year 2000

Number of shared co-authors 2

Lianbo Yu

The Ohio State University

Career Start Year 1997

Number of shared co-authors 1

Seunghee Kim-Schulze

Icahn School of Medicine at Mount Sinai

Career Start Year 1996

Number of shared co-authors 16

Jenny Xiang

Caryl and Israel Englander Institute for Precision Medicine.

Career Start Year 1993

Number of shared co-authors 2

Richard H Scheuermann

J. Craig Venter Institute

Career Start Year 1983

Number of shared co-authors 18

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Career Start Year 1974

Number of shared co-authors 18

row(s) 1 - 30 of 30